French microbiome biotechnology firm Enterome has signed a global licensing, co-development and co-promotion agreement with major pharmaceutical player Takeda.
Liquid I.V., a development stage company that has found success with clever marketing of its hydration beverage, has secured $5 million in a star-studded private funding round.
Reckitt Benckiser and Kellogg are said to have joined the race to purchase GSK consumer nutrition business – with Nestlé, Unilever, Mondelēz and Coca-Cola already reportedly interested in the business.
Riding on the ‘clean label’ sports nutrition movement, beverage giant Coca-Cola announced that it is acquiring a minority stake in BodyArmor, structured to lead to a full acquisition.
From Clorox to Kirin to Johnson & Johnson, this year we’ve seen several consumer packaged goods (CPG) giants enter the dietary supplement space, either through acquisitions or major investments.
In its first foray into the supplement realm, Johnson & Johnson Consumer Inc. has acquired Zarbee’s, Inc., a manufacturer of dietary supplements and OTC remedies with Supplement Facts panels.
The founders of New Chapter have severed their relationship with Procter & Gamble because they said “financial pressures to accelerate profits” meant they could no longer in good conscience continue to associate themselves with the brand.
Global ingredients maker DuPont Nutrition & Health is divesting its alginates business to Germany-headquartered JRS Group, a specialist in functional additives and plant-based raw materials.
Since its acquisition of natural extract supplier Indfrag for $35 million last year, OmniActive Health Technologies is solidifying its presence in the US specialty botanicals and extracts market with a focus on healthy aging and healthy living.
CPG giant The Clorox Company has been growing its footprint in the dietary supplement space through acquisitions. During its recent earnings call, the company’s execs fielded questions concerning the logic behind its most recent purchase.
LabCorp announced today that it has entered a definitive agreement to sell its Covance Food Solutions business to Eurofins Scientific for $670 million.
Procter & Gamble will buy Merck KGaA’s consumer health unit for €3.4 billion euros – as the FMCG giant looks stem falling revenue by betting on vitamin ranges that have shown stable growth.
